However, existing iron chelators exhibit side effects in clinical applications, including gastrointestinal discomfort, hepatotoxicity, and nephrotoxicity ( Based on TfR1-mediated iron uptake and ferroptosis mechanisms, researchers are exploring possibly delaying OA progression by intervening in ferroptosis
The use of N-acetylcysteine as a chelator for metal toxicity
Increased self-esteem, improved mood, higher energy levels, and a greater capacity for physical activity are commonly reported
Semaglutide treatment resulted in a 24% reduction in major kidney disease, a composite of kidney failure, at least a 50% reduction in estimated glomerular filtration rate from baseline or death from kidney-associated or cardiovascular causes
Procurement strategies for peptide APIs in pharmaceutical development: Quality, compliance, and supply chain considerations